Literature DB >> 4466566

In vitro stimulation of spleen cell cultures by poly I: poly C and levamisole.

W A Woods, M J Siegel, M A Chirigos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4466566     DOI: 10.1016/0008-8749(74)90217-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  7 in total

1.  The in vitro evaluation of certain neutrophil and lymphocyte functions following the ingestion of 150 mg oral dose of levamisole: assessment of the extent and duration of stimulation of neutrophil chemotaxis, protein iodination and lymphocyte transformation.

Authors:  R Anderson; R Oosthuizen; A Theron; A J Van Rensburg
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

2.  Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.

Authors:  J Zulman; J Michalski; C McCombs; J Greenspan; N Talal
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

3.  In vitro stimulation of murine lymphoid cell cultures by levamisole.

Authors:  V J Merluzzi; A M Badger; C W Kaiser; S R Cooperband
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

4.  Enhanced resistance to Corynebacterium pseudotuberculosis infections associated with reduced serum immunoglobulin levels in levamisole-treated mice.

Authors:  M R Irwin; H D Knight
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

5.  Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation.

Authors:  J W Hadden; E M Hadden; R G Coffey
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

6.  In vitro reversal of cellular unresponsiveness induced by levamisole.

Authors:  H Golding; B Golding; R Jacobson; R Lomnitzer; H J Koornhof; A R Rabson
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

7.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.